Eli Lilly is an Indianapolis-based pharmaceutical company and corporate venture investor that backs external biotech and life sciences innovation through Lilly Ventures, Lilly Gateway Labs, Lilly ExploR&D and Lilly Catalyze360. It invests and partners across early-stage and later-stage opportunities, with focus areas including oncology, genetic medicines, immunology, neuroscience, cardiometabolic health, digital health, AI-enabled discovery and molecule innovation. The company invests in the United States, Europe and globally, and is most relevant to founders building therapeutics, drug-discovery platforms or strategic biopharma technologies.